Comment on 'High rates of antibiotic prescriptions in children with COVID-19 or multisystem inflammatory syndrome: A multinational experience in 990 cases from Latin America

Acta Paediatr. 2021 Sep;110(9):2648-2649. doi: 10.1111/apa.15980. Epub 2021 Jun 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • COVID-19*
  • Child
  • Humans
  • Latin America
  • Prescriptions
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related